Nov 6, 2025 07:04AM
Nov 6, 2025 07:04AM
Oct 15, 2025 07:00AM
Oct 15, 2025 07:00AM
Sep 25, 2025 07:00AM
Sep 19, 2025 04:39PM
Jun 30, 2025 05:29PM Algernon Announces Amended Terms for Private Placement and Closing of the First Tranche totaling $621,000
May 22, 2025 08:50PM
May 13, 2025 07:00AM
Aug 2, 2024 07:00AM
Jul 31, 2024 07:00AM
Jul 16, 2024 08:00AM
May 21, 2024 07:00AM
Apr 24, 2024 07:47AM Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
Apr 11, 2024 07:00AM
Mar 27, 2024 12:04PM
Dec 27, 2023 07:00AM
Dec 12, 2023 07:42PM
Nov 22, 2023 07:00AM
Jul 14, 2023 06:00PM
Jun 27, 2023 07:00AM Algernon Pharmaceuticals Engages Maxim Group to Explore Spin-Off of its Ifenprodil Phase 2 Chronic Cough Drug Development Program
Apr 20, 2023 07:00AM
Mar 21, 2023 07:00AM
Jan 11, 2023 07:00AM
Jan 9, 2023 07:00AM
Feb 23, 2022 07:00AM
Nov 24, 2021 07:00AM
Nov 1, 2021 03:25PM The Power Play by The Market Herald Releases New Interviews with Datametrex, Group Ten Metals, Algernon Pharmaceuticals and Alianza Minerals Discussing Their Latest News
Aug 11, 2021 07:00AM
Aug 9, 2021 07:00AM
Mar 5, 2021 07:31PM
Dec 30, 2020 08:00AM
Apr 20, 2020 07:45AM
Feb 21, 2020 06:00AM
Feb 13, 2020 09:00AM Algernon Pharmaceuticals Announces Private Placement

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All